The Evidence Strategy team, part of Trinity’s Evidence, Value, Access and Pricing (EVAP) group, supports biotech, pharma, and medical device clients with evidence planning, value demonstration, and scientific communication through real‑world health economics and outcomes research (HEOR). For more than 30 years, the world’s leading pharmaceutical, biotech, and medtech companies have relied on Trinity’s foresight, execution, and partnership to deliver confident product launches, decisive market advantage, and measurable patient impact.